For prescription only.
THADO must be only administered in compliance with all the instructions outlined in the informed consent form. Drugs prescribing to women of childbearing potential must be contingent upon initial and continued confirmed negative results of pregnancy testing. (Please refer to PRECAUTIONS.)
Multiple Myeloma (MM) - THADO should be initiated at 200 mg/day and not more than 800 mg/day, administered once daily with water, preferably at bedtime and at least 1 hour after evening meal.
- Patients should not take double doses of THADO in one time, when patients miss one dose of THADO, patients should make up as soon as possible but the timing of dose making up should not be close to the next dose.